TipRanks
Milestone Pharmaceuticals (MIST)
NASDAQ:MIST
US Market
MIST
Milestone Pharmaceuticals
RESEARCH TOOLSreports
Want to see MIST full AI Analyst Report?

Milestone Pharmaceuticals (MIST) Stock News & Sentiment

821 Followers
Milestone Wins China Approval for Etripamil Nasal Spray
Premium
Company Announcements
Milestone Wins China Approval for Etripamil Nasal Spray
1M ago
8K
MIST
Analyst Ritu Baral Initiates Buy on Cardamyst, Citing Strong Early Launch Metrics, Improving Reimbursement Outlook, and Solid Cash Runway
Premium
Ratings
Analyst Ritu Baral Initiates Buy on Cardamyst, Citing Strong Early Launch Metrics, Improving Reimbursement Outlook, and Solid Cash Runway
2M ago
MIST
Milestone Pharmaceuticals’ Earnings Call Flags Risk and Momentum
Premium
Company Announcements
Milestone Pharmaceuticals’ Earnings Call Flags Risk and Momentum
2M ago
MIST
Milestone Pharmaceuticals: Strong CARDAMYST Launch Metrics and Expanded Coverage Support Unchanged $8 Price Target and Buy Rating
Premium
Ratings
Milestone Pharmaceuticals: Strong CARDAMYST Launch Metrics and Expanded Coverage Support Unchanged $8 Price Target and Buy Rating
2M ago
MIST
Milestone Pharmaceuticals (MIST) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Milestone Pharmaceuticals (MIST) Q2 Earnings Cheat Sheet
2M ago
MIST
Milestone Pharmaceuticals Shareholders Approve Governance and Compensation Measures
Premium
Company Announcements
Milestone Pharmaceuticals Shareholders Approve Governance and Compensation Measures
4M ago
8K
MIST
Milestone Pharmaceuticals’ Earnings Call Signals Early Momentum
Premium
Company Announcements
Milestone Pharmaceuticals’ Earnings Call Signals Early Momentum
5M ago
MIST
More MIST News >

MIST News on the Web

Milestone Enrolls First Canadian Patient In Phase 3 For Etripamil
rttnews
Bullish
Cantor starts Milestone Pharmaceuticals at Overweight, sees 200% upside
TipRanks News
Bullish
Milestone Pharmaceuticals (MIST) Q2 Earnings Cheat Sheet
TipRanks News
Neutral
Milestone Pharmaceuticals Shareholders Approve Governance and Compensation Measures
TipRanks News
Neutral
Milestone (MIST) Q1 2026 Earnings Transcript
The Motley Fool
Neutral
Analysts Offer Insights on Healthcare Companies: Alpha Tau Medical Ltd (DRTS), Neurogene (NGNE) and Milestone Pharmaceuticals (MIST)
TipRanks News
Bullish
Milestone Pharmaceuticals’ Earnings Call Signals Early Momentum
TipRanks News
Bullish
Milestone Pharmaceuticals (MIST) Gets a Buy from Piper Sandler
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
MIST
Sector Average
Media Buzz
This Week4 articles
Weekly Average0.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MIST’s Media Buzz Sentiment?
4 articles about MIST were published this week. In an average week, 0.75 articles are published.
    What is MIST’s weekly average amount of articles?
    In an average week, 0.75 articles about MIST are published.
      What is MIST’s News Sentiment?
      100% of articles about MIST were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        AMGNAmgen
        GKOSGlaukos
        OVIDOvid Therapeutics
        ABTAbbott Laboratories
        IQVIQVIA Holdings
        Showing the stocks with the most bullish news sentiment over the past week